Therapeutic management of acute respiratory infections in AIEPI

Abstract

To determine the therapeutic management of acute respiratory infections within the IMCI strategy in children from 2 to 59 months in the health centres of Déleg, Javier Loyola and San Miguel de Porotos. Materials and Methods: Descriptive study, cross-sectional, quantitative, sample of 314 children attended in the health center Déleg, Javier Loyola and San Miguel de Porotos, diagnosed with acute respiratory infection. Instrument: A collection form was designed with the respective validation by experts. Data were collected from the medical history of children from 2 to 59 months. Results: Male predominance 56.7%, age 2 to 11 months 28.6%, predominance of cough or common cold 31.4% followed by pharyngo-tonsillitis 22.2%, therapeutic management of pharyngo-tonsillitis is based on the use of amoxicillin and paracetamol 54.5%, in cough or cold receive paracetamol 30.8% and other children with the same diagnosis receive paracetamol plus loratadine 72%. In simple counseling, sore throat relief predominates 80.0% and cough relief 65%. Conclusion: The classification specified in the IMCI strategy is not met. There is a high percentage of diagnoses of pharyngo-tonsillitis that are not specified as being viral or bacterial, and other cases are treated with amoxicillin plus clavulanic acid.